Literature DB >> 21144428

Extended measures for controlling an outbreak of VIM-1 producing imipenem-resistant Klebsiella pneumoniae in a liver transplant centre in France, 2003-2004.

N Kassis-Chikhani1, F Saliba, A Carbonne, S Neuville, D Decre, C Sengelin, C Guerin, N Gastiaburu, A Lavigne-Kriaa, C Boutelier, G Arlet, D Samuel, D Castaing, E Dussaix, V Jarlier.   

Abstract

We report the successful control of an outbreak caused by imipenem-resistant VIM-1-producing Klebsiella pneumoniae (IR-Kp) in France. This outbreak occurred in a care centre for abdominal surgery that includes a 15-bed liver intensive care unit and performs more than 130 liver transplantations per year. The index case was a patient with acute liver failure transferred from a hospital in Greece for urgent liver transplantation who was carrying IR-Kp at admission as revealed by routine culture of a rectal swab. Infection control measures were undertaken and included contact isolation and promotion of hand hygiene with alcohol-based hand rub solution. Nevertheless, secondary IR-Kp cases were identified during the six following months from 3 December 2003 to 2 June 2004. From 2 June to 21 October, extended infection control measures were set up, such as cohorting IR-Kp carriers, contact patients and new patients in distinct sections with dedicated staff, limiting ward admission, and strict control of patient transfer. They led to a rapid control of the outbreak. The global attack rate of the IR-Kp outbreak was 2.5%, 13% in liver transplant patients and 0.4% in the other patients in the care centre (p<0.005). Systematic screening for IR-Kp of all patients admitted to the care centre is still maintained to date and no secondary IR-Kp case has been detected since 2 June 2004.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21144428     DOI: 10.2807/ese.15.46.19713-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  11 in total

1.  Nosocomial outbreak of VIM-1-producing Klebsiella pneumoniae isolates of multilocus sequence type 15: molecular basis, clinical risk factors, and outcome.

Authors:  Isabel Sánchez-Romero; Angel Asensio; Jesús Oteo; María Muñoz-Algarra; Beatriz Isidoro; Ana Vindel; José Alvarez-Avello; Bárbara Balandín-Moreno; Oscar Cuevas; Sara Fernández-Romero; Luisa Azañedo; David Sáez; José Campos
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

Review 2.  Carbapenem-resistant Enterobacteriaceae in special populations: Solid organ transplant recipients, stem cell transplant recipients, and patients with hematologic malignancies.

Authors:  Stephanie M Pouch; Michael J Satlin
Journal:  Virulence       Date:  2016-07-28       Impact factor: 5.882

3.  A Systematic Review and Meta-analyses of the Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae.

Authors:  Karlijn van Loon; Anne F Voor In 't Holt; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

Review 4.  Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.

Authors:  L S Tzouvelekis; A Markogiannakis; M Psichogiou; P T Tassios; G L Daikos
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

Review 5.  Multidrug-resistant bacterial infections after liver transplantation: an ever-growing challenge.

Authors:  Guilherme Santoro-Lopes; Erika Ferraz de Gouvêa
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

6.  Twenty years of antimicrobial resistance control programme in a regional multi hospital institution, with focus on emerging bacteria (VRE and CPE).

Authors:  Sandra Fournier; Christian Brun-Buisson; Vincent Jarlier
Journal:  Antimicrob Resist Infect Control       Date:  2012-02-13       Impact factor: 4.887

7.  A longitudinal assessment of antimicrobial susceptibility among important pathogens collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) in France between 2004 and 2012.

Authors:  Vincent Cattoir; Michael J Dowzicky
Journal:  Antimicrob Resist Infect Control       Date:  2014-12-01       Impact factor: 4.887

8.  Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018.

Authors:  Philipp Kohler; Aline Wolfensberger; Susanne Stampf; Andreas Brönnimann; Katia Boggian; Christian van Delden; Melody Favre; Cédric Hirzel; Nina Khanna; Stefan P Kuster; Oriol Manuel; Dionysios Neofytos; Silvio Ragozzino; Peter W Schreiber; Laura Walti; Nicolas J Mueller
Journal:  Antimicrob Resist Infect Control       Date:  2021-03-07       Impact factor: 4.887

9.  Transmission dynamics of carbapenemase-producing Klebsiella pneumoniae and anticipated impact of infection control strategies in a surgical unit.

Authors:  Vana Sypsa; Mina Psichogiou; Georgia-Aikaterina Bouzala; Linos Hadjihannas; Angelos Hatzakis; Georgios L Daikos
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

Review 10.  Use of ward closure to control outbreaks among hospitalized patients in acute care settings: a systematic review.

Authors:  Holly Wong; Katherine Eso; Ada Ip; Jessica Jones; Yoojin Kwon; Susan Powelson; Jill de Grood; Rose Geransar; Maria Santana; A Mark Joffe; Geoffrey Taylor; Bayan Missaghi; Craig Pearce; William A Ghali; John Conly
Journal:  Syst Rev       Date:  2015-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.